Julian Robertson Gilead Sciences, Inc. Transaction History

Tiger Management L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $2.09 Million - $2.72 Million	-34,460 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $288,755 - $319,704	-4,051 Reduced 10.52%	34,460 $2.66 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $2.78 Million - $3.29 Million	38,511	38,511 $3.12 Million

1,917

10.9M

9.67M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Tiger Management L.L.C., based on Form 13F filings with the SEC.

Stay updated on Tiger Management L.L.C. and Julian Robertson with notifications on news.